¾Ð¹Ú°æÈ­¿ä¹ýÀ» ÀÌ¿ëÇÑ ÀÏÂ÷¼º ÇÏÁöÁ¤¸Æ·ùÀÇ Ä¡·á
(Compression Sclerotherapy for Primary Varicose Vein
of the Lower Extremities)


½ÅµÎÇÑ¡¤±è¿¬¼ö¡¤È«ÀÎÇ¥¡¤±èÁ¾È¯¡¤0|¼¼ÀÏ*¡¤±è³²È£+¡¤½É¿µ±â+
±¹¸³ÀÇ·á¿ø ¼ºÇü¿Ü°ú
ÀÎÇÏ´ëÇк´¿ø ¼ºÇü¿Ü°ú*
½É¿µ±â ¼ºÇü¿Ü°ú+

Áõ·Ê 1 (±×¸²1)
33¼¼ ¿©ÀÚ È¯ÀÚ·Î ÇÏÁöºÎ¿¡ Á÷°æ 6 mm Å©±âÀÇ Á¤¸Æ·ù°¡ Àִ ȯÀÚ·Î 1.5% Fibrovein(sodium tetradecyl sulfate)À» 1ÁÖÀÏ °£°ÝÀ¸·Î 2ȸ ÁÖ»çÇÏ¿© Ä¡À¯µÇ¾ú°í 2°³¿ù°£ ¾Ð¹Ú½ºÅ¸Å·¿Ã Âø¿ë½ÃÄ×´Ù.

[±×¸² 1] (left) A 33 year old female patient with earthmworm like varlcose vein. (Right) Sclerotherapy was performed with 1.5% Fibrovein (sodium tetradecyl sulfate) twice with 1 week interval. Compression stockings were applied for 8 weeks. 6 months after the operation.

Áõ·Ê 2 (±×¸² 2)
42¼¼ ¿©ÀÚ È¯ÀÚ·Î ÇÏÁöºÎ¿¡ Æ÷µµ»ó ¸ð¾çÀÇ Á¤¸Æ·ù°¡ Àִ ȯÀÚ·Î 3% FibroveinÀ» 1ÁÖÀÏ °£°ÝÀ¸·Î 3ȸ ÁÖ»çÇÏ¿© Ä¡À¯µÇ¾ú°í 3°³¿ù°£ ¾Ð¹Ú½ºÅ¸Å·À» Âø¿ë½ÃÄ×´Ù.

[±×¸² 2] (left) A 42 year old female patient with typical grape like varicose vein (type 2). (right) Sclerotherapy was performed with 3% fibrovein (sodium tetradecyl sulfate) 3 times with 1 week interval. Compression stockings were applied for 12 weeks. 12 months after the operation

Áõ·Ê 3 (±×¸² 3)
52¼¼ ³²ÀÚ È¯ÀÚ·Î ¿ìÃø ÇÏÁöºÎ¿¡ ¸Á»óÁ¤¸Æ(rednllaI vem)ÀÇÈ®ÀåÀÌ Àִ ȯÀÚ·Î 0.5% FibroveinÀ» 1ÁÖÀÏ °£°ÝÀ¸·Î 2ȸ ÁÖ»çÇÏ¿© Ä¡À¯µÇ¾ú°í 2°³¿ù°£ ¾Ð¹Ú½ºÅ¸Å·À» Âø¿ë½ÃÄ×´Ù.

[±×¸² 3] (left) A 52-year-old male patient with varicose vein. (right) Sclerotherapy was performed with 0.5% fibrovein (sodium tetradecyl sulfate) for 2 times with 1 week intervals and compression stockings were applied for 8 weeks. 16 months after the operation

3. °á°ú

°¡.¿¬·É ¹× ¼º¹ú ºÐÆ÷
¿ø¹ß¼º ÇÏÁöÁ¤¸Æ·ù·Î ÀÔ¿øÇÑ È¯ÀÚ 549¸í(765¿¹)Áß ³²¼ºÀÌ 70¸íÀ̾ú°í ¿©¼ºÀÌ 479¸íÀ¸·Î ³²³àÀÇ ºñ´Â 1:6.8À̾ú´Ù. ¿¬·ÉºÐÆ÷´Â 40´ë¿¡¼­ 217¸í(303¿¹)À¸·Î °¡Àå ¸¹¾Ò°í30´ë¿¡¼­ ´Â 175¸í(218¿¹),50´ë¿¡¼­´Â 95¸í(142¿¹), 60´ë¿¡¼­´Â 39¸í(62¿¹)À̾ú´Ù. ÀÌÁß ¾çÃø¼ºÀÎ °æ¿ì´Â 216¸í(40%), ÆíÃø¼ºÀÎ °æ¿ì´Â 333¸í(60%)À̾ú´Ù (Table 1).

Age No. of limbs(%) No. of patients(%) Unilateral/

bilateral
(No. of patients)
0-10
11-20
21-30
31-40
41-50
51-60
61-70
71-
Total
0 (0%)
0 (0%)
34 (4%)
218 (28%)
303 (40%)
142 (19%)
62 (8%)
6 (1%)
765 (100%)
0 (0%)
0 (0%)
20 (4%)
175 (32%)
217 (39.5%)
95 (17%)
39 (7%)
3 (0.5%)
549 (100%)
0
0
6
132
131
48
16
0
333
0
0
14
43
86
47
23
3
216
[Table 1]. Age Distribution of Varicose Veins Patients

³ª.º´·Â±â°£
Á¤¸Æ·ùÀÇ °æ°ú ±â°£À» º¸¸é 5³â ÀÌÇÏÀÇ °æ¿ì°¡ 193¸í(35%)À̾ú°í, 6-10³âÀÌ 297¸í (54%),10³â ÀÌ»óÀÌ 59¸í(11%)·Î ´ëºÎºÐÀÌ 10³â ÀÌÇÏÀÇ °æ°ú±â°£À» °¡Áø ȯÀÚ¿¡¼­ Ç÷°ü °æÈ­¿ä¹ýÀÇ ÀûÀÀÁõÀÌ µÇ¾ú´Ù (Table 2).

Duration (year) No. of Patients (%)
0-05
06-10
11-15
16-20
21-25
26-30
Total
193 (35%)
297 (54%)
38 (7%)
16 (3%)
5 (1%)
0 (0%)
549 (100%)
[Table 2] Duration of Varicose Veins

´Ù.Áõ »ó
Á¤¸Æ·ùÀÇ Áõ»óÀ¸·Î °¡Àå ¸¹¾Ò´ø °ÍÀº ¹Ì¿ëÀûÀÎ ÀÌÀ¯°¡ 466¿¹(85%)À̾ú°í, µ¿ÅëÀÌ 230¿¹ (42%), Á߾а¨ÀÌ 98¿¹(18%), ÇÏÁöÀÇ ºÎÁ¾ÀÌ 55¿¹(10%), ÇǷΰ¨ÀÌ 32¿¹(6%) ÇǺο°ÀÌ 10¿¹(2%), ÇǺÎÂø»öÀÌ 5¿¹(1%) ¼øÀ̾ú´Ù (Table 3).

Symptom No. of Patients (%)
Cosmetic
Pain
Heaviness
Edema
Fatigue
Dermatitis
Cutaneous pigmentation
466 (85%)
230 (42%)
98 (18%)
55 (10%)
32 (6%)
10 (2%)
5 (1%)
[Table 3] Symptoms of Varicose Veins

¶ó.Ä¡·á°á°ú
Àüü 765¿¹Áß¿¡¼­ 107¿¹(14%)°¡ Ãß°¡ÀûÀÎ Ä¡·á°¡ ÇÊ¿äÇÏÁö ¾Ê¾Ò°í, 245¿¹(32%)´Â 2Â÷ ·Ê Ä¡·á°¡ ÇÊ¿äÇÏ¿´°í 368¸í(48%)Àº 3Â÷·Ê, 38¿¹(5%)´Â 4Â÷·Ê, 7¸í(1%)Àº 5Â÷·Ê¿¡ °É ÃÄ Ç÷°ü°æÈ­¿ä¹ýÀ» ½ÃÇàÇÏ¿´´Ù (Table4). ÃßÀûÁ¶»ç±â°£Àº 6°³¿ù¿¡¼­ 5³â±îÁö¿´°í Æò±Õ 1.4³âÀ̾ú´Ù. 1³âÈÄ¿¡ Àç¹ßµÈ °æ¿ì´Â 69¿¹(9%)¿¡¼­ ¹ß°ßµÇ¾ú°í Àç½Ã¼úÈÄ ¿ÏÄ¡µÇ¾ú´Ù. ´ë ºÎºÐÀÇ È¯ÀÚ°¡ ¼ö¼ú ¾øÀÌ ½Ã¼úÇÑ °Í°ú Áõ»óÀÇ °³¼±¿¡ ´ëÇÏ¿© Å©°Ô ¸¸Á·ÇÏ¿´°í ¾Ð¹Ú½ºÅ¸Å· ÀÇ Âø¿ëµµ ÆíÇÑ Âø¿ë°¨À¸·Î Å©°Ô ºÒÆíÇØ ÇÏÁö ¾Ê¾Ò´Ù.

Number of Sessions No. of Cases (%)
One
Two
Three
Four
Five
Total
107 (14%)
245 (32%)
368 (48%)
38 (5%)
7 (1%)
765 (100%)
[Table 4] Outcome of Treatment

¸¶.ÇÕº´Áõ
ºÎÀÛ¿ëÀ¸·Î´Â Ãʱâ 3¿¹¿¡¼­ Ç÷°ü¿Ü ÁÖ»ç·Î ÀÎÇÑ ÇǺÎÀÇ ±Ë¾çÀÌ ÀÖ¾ú°í ¾à¹°¿¡ ÀÇÇÑ °ú¹Î ¹ÝÀÀ µîÀÇ ºÎÀÛ¿ëÀº º¸ÀÌÁö ¾Ê¾Ò´Ù.±× ¿Ü¿¡ Ç÷Á¾ 54¿¹(7%),ÇǺÎÂø»ö 30¿¹(4%), ½Å»ýÇ÷°ü Çü¼º 38¿¹(5%), Ç¥ÀçÇ÷Àü¼º Á¤¸Æ¿° 4¿¹(0.5%)¼øÀ̾ú´Ù(Table V).

Complications No. of Cases (%)
Hematoma
Neovascularization
Hyperpigmentation
Asymptomatic thrombosis
Superficial thrombophlebitis
Skim ulceration
54 (7%)
38 (5%)
30 (4%)
8 (1%)
4 (0.5%)
3 (0.5%)
[Table 5] Complications

[ 1 ] [ 2 ] [ 3 ]

 

Prev

 Next